Annex 2. Summary of changes to recommendations

Table A2.1 summarizes changes to recommendations published in the 2012 WHO policy on collaborative TB/HIV activities (1). The 2012 policy contained (i) WHO recommendations, which were formulated using the GRADE approach, and (ii) operational recommendations not assessed using the GRADE methodology, which were developed during consultation with key stakeholders.

Definitions of actions for changes to recommendations developed using the GRADE approach are as follows.

  • New recommendation adopted: this relates to recommendations that have been newly developed by a guideline development group (GDG) since the publication of the 2012 TB/HIV policy.
  • Updated recommendation adopted: this relates to recommendations that have been rephrased since the publication of the 2012 TB/HIV policy, by a GDG.
  • Removed: recommendation is redundant or no longer valid and has hence been removed.
  • Edited: recommendation has been edited for language.

Table A2.1 Summary of changes to recommendations on HIV-associated TB

atab2-1a-pg-74atab2-1b-pg-75atab2-1c-pg-76atab2-1d-pg-77atab2-1e-pg-78atab2-1f-pg-79atab2-1g-pg-80atab2-1g-pg-81atab2-1g-pg-82atab2-1g-pg-83atab2-1g-pg-84atab2-1g-pg-85atab2-1g-pg-86atab2-1g-pg-87

Annex 2 References

  1. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Geneva: World Health Organization; 2012 (https://apps.who.int/iris/handle/10665/44789, accessed 31 August 2023).
  2. WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities. Geneva: World Health Organization; 2023.
  3. WHO consolidated guidelines on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/340255, accessed 31 August 2023).
  4. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detection, 2021 update. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/342331, accessed 31 August 2023).
  5. WHO consolidated guidelines on tuberculosis. Module 4: treatment – drug-susceptible tuberculosis treatment. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/353829, accessed 31 August 2023).
  6. Diagnosing and managing disseminated histoplasmosis among people living with HIV. Washington, D.C.: Pan American Health Organization, World Health Organization; 2020 (https://iris.paho.org/bitstream/handle/10665.2/52304/9789275122495_eng.pdf, accessed 26 September 2023).
  7. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, 2021 update. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/342899, accessed 31 August 2023).
  8. WHO consolidated guidelines on tuberculosis. Module 1: prevention – tuberculosis preventive treatment. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/331170, accessed 31 August 2023).
  9. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – tests for tuberculosis infection. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/362936, accessed 31 August 2023).
  10. Guidance for national tuberculosis programmes on the management of tuberculosis in children – 2nd ed. Geneva: World Health Organization; 2014 (https://apps.who.int/iris/handle/10665/112360, accessed 26 September 2023).
  11. WHO consolidated guidelines on tuberculosis. Module 4: treatment – drug-resistant tuberculosis treatment, 2022 update. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/365308, accessed 31 August 2023).
Convert to pdf
Off

Book navigation